Search Results | MSF Science Portal

Journal Article

|

Research

Koyuncu A, Asilaza KV, Rumunu J, Wamala J, Gitahi P, et al.

2025-03-06 • PLOS Global Public Health

In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...

Journal Article

|

Research

Nesbitt RC, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P, et al.

2025-01-08 • Lancet Infectious Diseases

BACKGROUND

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...

Journal Article

|

Research

Nesbitt RC, Azman AS, Asilaza VK, Edwards JK, Gitahi P, et al.

2024-11-01 • Lancet Global Health

Journal Article

|

Short Report

Ratnayake R, Knee J, Cumming O, Saidi JM, Rumedeka BB, et al.

2024-08-01 • Emerging Infectious Diseases

We evaluated the spatiotemporal clustering of rapid diagnostic test−positive cholera cases in Uvira, eastern Democratic Republic of the Congo. We detected spatiotemporal clusters that...

Conference Material

|

Poster

Moser W, Broban A, Welo PO, Mukadi D, Gerstl S, et al.

2024-05-23 • Epicentre Scientific Day 2024

Conference Material

|

Slide Presentation

Finger F, Mimbu N, Ratnayake R, Meakin S, Bahati JB, et al.

2024-05-16 • MSF Scientific Day International 2024

Conference Material

|

Slide Presentation

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P, et al.

2024-05-16 • MSF Scientific Day International 2024

Conference Material

|

Abstract

Finger F, Mimbu N, Ratnayake R, Meakin S, Bahati JB, et al.

2024-05-16 • MSF Scientific Day International 2024

INTRODUCTION
The risk of cholera outbreaks spreading rapidly and extensively is substantial. Case-area targeted interventions (CATI) are based on the premise that early detection can...

Conference Material

|

Abstract

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P, et al.

2024-05-16 • MSF Scientific Day International 2024

INTRODUCTION

Hepatitis E causes high mortality among pregnant women, with case fatality risks over 30% and adverse fetal outcomes. There is an evidence gap on the safety of the ...

Journal Article

|

Research

Bugeme PM, Xu H, Hutchins C, Dent J, Saidi JM, et al.

2024-02-01 • Open Forum Infectious Diseases

Our understanding of the burden and drivers of cholera mortality is hampered by limited surveillance and confirmation capacity. Leveraging enhanced clinical and laboratory surveillance i...

Journal Article

|

Research

Nesbitt RC, Asilaza VK, Gignoux EM, Koyuncu A, Gitahi P, et al.

2024-01-22 • PLOS Neglected Tropical Diseases

INTRODUCTION

Hepatitis E (HEV) genotypes 1 and 2 are the common cause of jaundice and acute viral hepatitis that can cause large-scale outbreaks. HEV infection...

Conference Material

|

Abstract

Nesbitt RC, Rumunu J, Asilaza VK, Gitahi P, Nkemenang P, et al.

2023-06-07 • MSF Scientific Day International 2023

INTRODUCTION
A three-dose recombinant vaccine against hepatitis E, Hecolin, has been licensed for use in China since 2011. While not recommended for routine use due to lack of eviden...

Conference Material

|

Poster

Nesbitt RC, Rumunu J, Asilaza VK, Gitahi P, Nkemenang P, et al.

2023-06-07 • MSF Scientific Day International 2023

Conference Material

|

Slide Presentation

Nesbitt RC, Rumunu J, Asilaza VK, Gitahi P, Nkemenang P, et al.

2023-06-07 • MSF Scientific Day International 2023

Journal Article

|

Letter

Azman AS, Gignoux E, Nesbitt R, Rumunu J, Aggarwal R, et al.

2023-02-01 • Emerging Infectious Diseases

Journal Article

|

Research

Zheng Q, Luquero FJ, Ciglenecki I, Wamala JF, Abubakar A, et al.

2022-09-01 • International Journal of Infectious Diseases

BACKGROUND
Cholera remains a public health threat but is inequitably distributed across sub-Saharan Africa. Lack of standardized reporting and inconsistent outbreak definitions limit...

Journal Article

|

Letter

Ciglenecki I, Rumunu J, Wamala JF, Nkemenang P, Duncker J, et al.

2022-08-01 • Lancet Infectious Diseases

Protocol

|

Research Protocol

Ratnayake R, Peyraud N, Ciglenecki I, Gignoux EM, Lightowler M, et al.

2022-07-06 • BMJ Open

INTRODUCTION
Cholera outbreaks in fragile settings are prone to rapid expansion. Case-area targeted interventions (CATIs) have been proposed as a rapid and efficient response strateg...

Journal Article

|

Research

Jones FK, Wamala JF, Rumunu J, Mawien PN, Kol MT, et al.

2020-12-01 • Lancet Planetary health

Background
Between 2014 and 2017, successive cholera epidemics occurred in South Sudan within the context of civil war, population displacement, flooding, and drought. We aim to des...

Journal Article

|

Letter

Azman AS, Luquero FJ

2016-08-18 • New England Journal of Medicine

Science Portal

High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan

Spatiotemporal modeling of cholera, Uvira, Democratic Republic of the Congo, 2016−2020

A multi-site pilot study of the deployment of cholera rapid diagnostic tests in the Democratic Republic of the Congo

Case-area targeted interventions to rapidly contain the spread of cholera - a prospective observational study in the Democratic Republic of the Congo

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Case-area targeted interventions to rapidly contain the spread of cholera: a prospective observational study in the Democratic Republic of the Congo

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Cholera deaths during outbreaks in Uvira, Eastern Democratic Republic of the Congo, 10-35 months after mass vaccination

Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan

Two-dose vaccine effectiveness following the first reactive mass vaccination campaign against hepatitis E in Bentiu, South Sudan

Vaccination coverage and adverse events following immunisation after the first reactive mass vaccination campaign against Hepatitis E in Bentiu, South Sudan

Two-dose vaccine effectiveness following the first reactive mass vaccination campaign against Hepatitis E in Bentiu, South Sudan

Hepatitis E virus outbreak among Tigray War refugees from Ethopia, Sudan

Cholera outbreaks in sub-Saharan Africa during 2010-2019: a descriptive analysis

The first reactive vaccination campaign against hepatitis E

Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study

Successive epidemic waves of cholera in South Sudan between 2014 and 2017: a descriptive epidemiological study

Single-dose oral cholera vaccine in Bangladesh